Company intelligence / Profile preview

AutoGenomics

Carlsbad, California, United States

Ownership: Private
Development stage: Other

Overview

AutoGenomics is a biotech company specializing in molecular diagnostics, providing advanced genomic technologies to enhance personalized medicine. The company developed the INFINITI Analyzer, a fully automated multiplexing microarray platform, and offers a range of diagnostic tests across various disease areas.

Therapeutic areas: CardiovascularInfectious DiseasesRare DiseasesPsychiatryOncology
Modalities: Diagnostic Microarrays
Industry: Molecular Diagnostics

Partnerships

Prescient Medicine Holdings Inc. (now SOLVD Health)

Beyond the preview

Go deeper on AutoGenomics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AutoGenomics.

Explore the full profile